Journal Articles

Donald and Barbara Zucker School of Medicine
Academic Works

2015

Risk of venous congestion in live donors of
extended right liver graft
A. Radtke
G. Sgourakis
E. P. Molmenti
Zucker School of Medicine at Hofstra/Northwell

S. Beckebaum
V. R. Cicinnati
See next page for additional authors

Follow this and additional works at: https://academicworks.medicine.hofstra.edu/articles
Part of the Surgery Commons
Recommended Citation
Radtke A, Sgourakis G, Molmenti EP, Beckebaum S, Cicinnati V, Schmidt H, Peitgen H, Broelsch C, Malago M, Schroeder T. Risk of
venous congestion in live donors of extended right liver graft. . 2015 Jan 01; 21(19):Article 1889 [ p.]. Available from:
https://academicworks.medicine.hofstra.edu/articles/1889. Free full text article.

This Article is brought to you for free and open access by Donald and Barbara Zucker School of Medicine Academic Works. It has been accepted for
inclusion in Journal Articles by an authorized administrator of Donald and Barbara Zucker School of Medicine Academic Works. For more
information, please contact academicworks@hofstra.edu.

Authors

A. Radtke, G. Sgourakis, E. P. Molmenti, S. Beckebaum, V. R. Cicinnati, H. Schmidt, H. O. Peitgen, C. E.
Broelsch, M. Malago, and T. Schroeder

This article is available at Donald and Barbara Zucker School of Medicine Academic Works:
https://academicworks.medicine.hofstra.edu/articles/1889

World J Gastroenterol 2015 May 21; 21(19): 6008-6017
ISSN 1007-9327 (print) ISSN 2219-2840 (online)

Submit a Manuscript: http://www.wjgnet.com/esps/
Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx
DOI: 10.3748/wjg.v21.i19.6008

© 2015 Baishideng Publishing Group Inc. All rights reserved.

ORIGINAL ARTICLE
Prospective Study
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Abstract
AIM: To investigate middle hepatic vein (MHV)
management in adult living donor liver transplantation
and safer remnant volumes (RV).
METHODS: There were 59 grafts with and 12
grafts without MHV (including 4 with MHV-5/8 recon
structions). All donors underwent our five-step protocol
evaluation containing a preoperative protocol liver
biopsy Congestive vs non-congestive RV, remnantvolume-body-weight ratios (RVBWR) and postoperative
outcomes were evaluated in 71 right graft living
donors. Dominant vs non-dominant MHV anatomy in
total liver volume (d-MHV/TLV vs nd-MHV/TLV) was
constellated with large/small congestion volumes (CVindex). Small for size (SFS) and non-SFS remnant
considerations were based on standard cut-off- RVBWR
and RV/TLV. Non-congestive RVBWR was based on
non-congestive RV.
RESULTS: MHV and non-MHV remnants showed no
significant differences in RV, RV/TLV, RVBWR, total
bilirubin, or INR. SFS-remnants with RV/TLV < 30%
and non-SFS-remnants with RV/TLV ≥ 30% showed
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no significant differences either. RV and RVBWR for
non-MHV (n = 59) and MHV-containing (n = 12)
remnants were 550 ± 95 ml and 0.79 ± 0.1 ml vs
568 ± 97 ml and 0.79 ± 0.13, respectively (P = 0.423
and P = 0.919. Mean left RV/TLV was 35.8% ± 3.9%.
Non-MHV (n = 59) and MHV-containing (n = 12)
remnants (34.1% ± 3% vs 36% ± 4% respectively,
P = 0.148. Eight SFS-remnants with RVBWR < 0.65
had a significantly smaller RV/TLV than 63 non-SFSremnants with RVBWR ≥ 0.65 [SFS: RV/TLV 32.4%
(range: 28%-35.7%) vs non-SFS: RV/TLV 36.2%
(range: 26.1%-45.5%), P < 0.009. Six SFS-remnants
with RV/TLV < 30% had significantly smaller RVBWR
than 65 non-SFS-remnants with RV/TLV ≥ 30% (0.65
(range: 0.6-0.7) vs 0.8 (range: 0.6-1.27), P < 0.01.
Two (2.8%) donors developed reversible liver failure.
RVBWR and RV/TLV were concordant in 25%-33%
of SFS and in 92%-94% of non-SFS remnants. MHV
management options including complete MHV vs MHV4A selective retention were necessary in n = 12 vs n =
2 remnants based on particularly risky congestive and
non-congestive volume constellations.

INTRODUCTION
The precise determination of graft and remnant
volumes constitutes the most important parameter to
prevent postoperative donor and recipient liver failure
[1-3]
in adult live donor liver transplantation (ALDLT) .
Middle hepatic vein (MHV)-containing grafts are
associated with small remnants whose function may
be further impaired by early postoperative venous
congestion of their medial sector (segment 4A/
[1,4,5]
B)
. The occurrence of small-for-size syndrome
(SFSS) in donors as a result of inadequate functional
remnant volume is a constant reminder of the
controversy surrounding venous congestion and MHV
management. The commonly accepted definitions for
small-for-size-(SFS)-remnants do not even consider
[4,6-11]
remnant volume values
. To date, there are no
published reports correlating the extent of functional
impairment and parenchymal congestion in non-MHV
containing remnants, and remnant volume limits
for safe MHV inclusion with the right graft are still
undefined.
In the present series, we evaluated our experience
with liver failure in right graft donors. Our goal was to
analyse the impact of MHV-containing right grafts on
remnant volume (RV) and function. We considered the
ratios remnant-volume-body-weight-ratio (RVBWR)
and remnant volume percentage of total liver volume
(RV/TLV) as a way to discriminate between SFS- and
non-SFS remnants based on commonly accepted cut
[4,8]
off values . The following queries were addressed:
(1) How concordant are these ratios in assessing SFSremnants and determining their volume limits? (2)
Is MHV procurement with right grafts associated with
substantial loss of remnant volume? (3) Does inclusion
of the MHV in right grafts impact remnant liver function
and donor morbidity as a result of venous congestion?
and (4) Does MHV anatomy affect venous outflow
(= congestive volume) and thereby influence MHV
management?
We finally considered “reasonable” criteria for
procurement of right grafts with/without complete
MHV vs selective MHV-4A preservation in remnants
based both on our own experience with donors
without evidence of steatosis as well as on that of
[4,6-8,11-16]
others
.

CONCLUSION: MHV procurement should consider
individual remnant congestive- and non-congestive
volume components and anatomy characteristics,
RVBWR-RV/TLV constellation enables the identification
of marginally small remnants.
Key words: Living donor liver transplantation; Liver
volume; Remnant volume; Small-for-size; Small-forsize syndrome
© The Author(s) 2015. Published by Baishideng Publishing
Group Inc. All rights reserved.

Core tip: Prevention of liver failure in middle hepatic
vein (MHV) inclusive right graft donors involves
consideration of both congestive and non-congestive
remnant volumes. MHV management should be
individually based on MHV anatomy characteristics.
Non-congestive volumes represent an important
safety parameter in MHV management, especially in
the setting of small for size remnants. The remnantvolume-body-weight ratios - remnant volumes/total
liver volume constellation seems to have a synergistic
(complementary) capacity for the identification of
marginally small remnants with the highest risk
potential of postoperative liver failure.

MATERIALS AND METHODS
Radtke A, Sgourakis G, Molmenti EP, Beckebaum S, Cicinnati
VR, Schmidt H, Peitgen HO, Broelsch CE, Malagó M, Schroeder
T. Risk of venous congestion in live donors of extended right
liver graft. World J Gastroenterol 2015; 21(19): 6008-6017
Available from: URL: http://www.wjgnet.com/1007-9327/full/
v21/i19/6008.htm DOI: http://dx.doi.org/10.3748/wjg.v21.
i19.6008
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Study population

From January 2003 to October 2007, 71 consecutive
live donors (36 females and 35 males, mean age 37 ±
10.1 years) underwent right graft hepatectomy at the
University Hospital Essen, Germany. There were 59
grafts with and 12 grafts without MHV (including 4 with
MHV-5/8 reconstructions). All donors underwent our
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Non-congestive volume: volume safely drained by
the left hepatic vein (LHV) tributaries.

Table 1 Etiology of liver disease among right graft recipients
(n = 71)
Parameter

Congestive volume-index: percentage of volume
with venous congestion.

Number

Total
Male
Female
Autoimmune hepatitis
Hepatitis B
Hepatitis B associated with hepatocellular carcinoma (HCC)
Hepatitis C
Hepatitis C associated with HCC
Alcoholic
Alcoholic + associated with HCC
Morbus Wilson
Primary biliary sclerosis (PBC)
Primary sclerosing cholangitis (PSC)
HCC
Cryptogenic
Others1

71
43
28
5
4
7
8
10
7
6
2
2
7
4
6
3

Donor RV/TLV: remnant volume percentage of total
liver volume considering the remnant volume with
intact bi-sectorial venous outflow via the middle (MHV)and LHV tributaries.
Donor RVBWR: (safely drained by MHV and LHV) vs
non-congestive RVBWR (safely drained by LHV) were
[9]
calculated according to the Heinemann formula .

3-D virtual liver partition

The “carving” transection plane followed the course of
the MHV, exposing it on the resection surface of either
graft (MHV-procurement) or remnant (MHV-retention)
[21]
livers . The MHV trunk served as a reproducible
surgical landmark for the exact extrapolation (by
means of color doppler scanning, IOUS) of the 3-D
liver model onto the operative field.

1

Neuroendocrine lever metastases (n = 2), liver metastases from
insulinoma.

five-step protocol evaluation containing a preoperative
[14,17]
protocol liver biopsy as previously described
.
Biopsy results in all resected donors showed less than
10% steatosis and no evidence of hepatopathologic
changes.

SFS vs non-SFS remnants

We evaluated the correlation between RVBWR and
RV/TLV as a way to distinguish between SFS- and
non-SFS remnant status based on the following cut
off values: SFS-remnant: RVBWR < 0.65 vs non-SFS[8]
remnant RVBWR ≥ 0.65 . SFS-remnant: RV/TLV<
[4]
30% vs non-SFS-remnant RV/TLV ≥ 30% .

Recipient indications for liver transplantation

Sixty eight out of 71 right graft recipients (28 females
and 43 males, mean age 50 ± 11.0 years) suffered
from liver cirrhosis classified for Child-A score; n = 22,
Child-B score; n = 33, Child-C score; n = 13, while
in the remaining n = 3 cases with no cirrhosis the
indication for liver transplantation were neuroendocrine
liver metastases (n = 2) as well as liver metastases
from insulinoma (n = 1, Table 1). The overall “Model of
End-Stage Liver Diesease”-score (MELD) was of mean
of 14 ± 8 (range: 11-40).

SFSS definition

computed tomography (CT) imaging was performed
using a 16-row-Multidetector-CT-Scanner (Sensa
®
tion16 , Siemens, Erlangen, Germany) as originally
[18]
published by our group .

SFSS was defined as either poor initial remnant
function or prolonged remnant dysfunction as a result
of inadequate functional liver mass in the absence
of other causative factors. This definition was based
on criteria for both LDLT donors and recipients
[22,23]
likewise tumor hepatectomy patients
. SFSS was
characterised by the presence of at least two of the
following symptoms within the first four post-operative
weeks: encephalopathy (stage ≥ 2), progressive
intrahepatic cholestasis [Bilirubin > 5.0 (reference
value: 0.2-1.2)], prolonged severe coagulopathy (INR
> 2.2), excessive intractable ascites (> 3 L/d).

3D-CT-imaging analysis and -volumetry

Hepatic vein dominance in total liver

Liver volume definitions

Statistical analysis

All-in-one protocol of multiphasic computed tomography
scan

Hepatic vein with the largest percentage of total liver
[20]
volume (TLV) as originally classified by our group .

CT images were analyzed with the software assistant
®
[19,20]
HepaVision (MeVis institute, Bremen, Germany)
.

The non-parametric Sign test was used for two
variables lacking normal distribution. The nonparametric Wilcoxon matched pairs test was applied to
test the hypothesis that two variables (lacking normal
distribution) were drawn from the same distribution.

RV: congestive and non-congestive volumes.
Congestive volume: venous congestion volume
resulting from the detachment of left sided MHV-(4A/B)
tributaries draining the left medial sector.

WJG|www.wjgnet.com
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A

Remnant status defined by Rvbwr
SFS
RVBWR < 0.65
n =8
RV/TLV < 30%
Concordant
2/8
25%
RV/TLV ≥ 30%
Non-concordant
6/8
75%

Remnant status defined by Rv/tlv

Non SFS
SFS
RVBWR ≥ 0.65 RV/TLV < 30%
n = 63
n =6
RV/TLV < 30% RVBWR < 0.65
Non-concordant
Concordant
4/63
2/61
6%
33%
RV/TLV ≥ 30% RVBWR ≥ 0.65
Concordant
Non-concordant
59/63
4/6
94%
67%

1

RV/TLV (%)

Table 2 Concordant vs non-concordant interrelation between
remnant volume (donor) body weight ratio and remnant
volume percentage of total liver volume in discriminating
small-for-size from non-small-for-size remnants according to
two different cut-off values

Non SFS
RV/TLV ≥ 30%
n = 65
RVBWR < 0.65
Non-concordant
5/652
8%
RVBWR ≥ 0.65
Concordant
60/65
92%

Median
25%-75%
Min-Max

RVBWR ≥ 0.65 RVBWR < 0.65
Group

B

1.3
1.2

2

incl. 2 remnants with RVBWR = 0.60; incl. 1 remnant with RVBWR = 0.60.
SFS: Small-for-size; RV/TLV: Remnant volume percentage of total liver
volume; RVBWR: Remnant volume (donor) body weight ratio.

1.1

RVBWR

1.0

The Mann-Whitney U Test was used to test the
significance of the difference between two independent
samples of an ordinal variable as well as differences
in the shape of the distributions (not just the location
of the ranks) of the two groups. Significance was
considered at a level < 0.05. Statistical release 7
(Statsoft) was used for statistical analysis.

0.9
0.8
0.7
0.6
0.5

RV/TLV ≥ 30% RV/TLV < 30%

Figure 1 Correlation between remnant-volume-(donor) body-weight ratio
(< 0.65 vs ≥ 0.65) and remnant volume percentage of total liver volume
in left remnants of 71 right graft donors (A) and correlation between
remnant volume percentage of total liver volume (< 30% vs ≥ 30%) and
remnant-volume-(donor) body-weight ratio in the left remnants of 71 right
graft donors (B). RV/TLV: Remnant volume percentage of total liver volume;
RVBWR: Remnant-volume-(donor) body-weight ratio.

RESULTS
RV and RVBWR

Mean overall RV and RVBWR were 565 ± 97 ml and
0.79 ± 0.12, respectively. RV and RVBWR for non-MHV
(n = 59) and MHV-containing (n = 12) remnants were
550 ± 95 ml and 0.79 ± 0.1 ml vs 568 ± 97 ml and
0.79 ± 0.13, respectively (p = 0.423 and p = 0.919,
Mann Whitney U test).

Thirty-three percent (n = 2/6) of SFS-remnants
had RV/TLV < 30% with RVBWR < 0.65. 92% (n =
60/65) of non-SFS-remnants had RV/TLV ≥ 30% and
RVBWR ≥ 0.65. Six SFS-remnants with RV/TLV <
30% had significantly smaller RVBWR than 65 nonSFS-remnants with RV/TLV ≥ 30% [0.65 (range:
0.6-0.7) vs 0.8 (range: 0.6-1.27), p < 0.01, Mann
Whitney U test] Figure 1B.

RV/TLV

Mean left RV/TLV was 35.8% ± 3.9%. Non-MHV (n =
59) and MHV-containing (n = 12) remnants (34.1%
± 3% vs 36% ± 4% respectively, p = 0.148 Mann
Whitney U test) showed no significant differences.

Congestive volume-index and non-congestive RVBWR

Correlation between donor RVBWR vs RV/TLV in
defining SFS-remnants

Mean overall congestive volume (CV) was 209.2 ±
77.6 ml (range: 40-459 ml) with a CV-index of 36.9
± 11.6 %RV (range: 6.1-70.2 %RV). Mean noncongestive [safely drained by the left hepatic vein
(LHV)] donor RVBWR (0.48 ± 0.12, range: 0.2-0.79)
was significantly smaller than the corresponding donor
RVBWR (safely drained by both MHV and LHV) (0.79 ±
0.12, range: 0.6-1.27, p < 0.0001, Wilcoxon’s signed
ranks test).

We assessed the concordance between RVBWR < 0.65
and RV/TLV < 30% in all 71 right graft donors (Table 2).
Twenty-five percent (n = 2/8) of SFS-remnants had
RVBWR < 0.65 with RV/TLV < 30%. 94% (n = 59/63)
of non-SFS-remnants had RVBWR ≥ 0.65 and RV/TLV
≥ 30%. Eight SFS-remnants with RVBWR < 0.65
had a significantly smaller RV/TLV than 63 non-SFSremnants with RVBWR ≥ 0.65 [SFS: RV/TLV 32.4%
(range: 28%-35.7%) vs non-SFS: RV/TLV 36.2%
(range: 26.1%-45.5%), p < 0.009, Mann Whitney U
test] Figure 1A.

WJG|www.wjgnet.com

48
46
44
42
40
38
36
34
32
30
28
26
24

Liver function laboratory markers

Non-MHV containing remnants had a higher (although
P values were very close) peak total bilirubin and INR
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ml = RV/TLV 31%). RV safely drained by LHV of 344
ml (CV-index = 40.2%), with safely (LHV)-drainedRVBWR of 0.39. Postoperatively developed grade 2°
encephalopathy, with peak bilirubin of 19.8 mg/dl and
INR of 2.5. Recovered spontaneously after a hospital
stay of 26 d.

Table 3 Comparison of early postoperative biochemical liver
function markers among right graft donors (n = 71)
Remnants
Peak
(mean ±
SD)

MHV

n = 12

Remnants

Remnants

Remnants

Non-MHV RV/TLV ≥ 30% RV/TLV < 30%

n = 59

Bilirubin 4.26 ± 2.86 5.54 ± 7.89
P = 0.544
(0.2-1.2)
INR (1.0) 1.99 ± 0.52 2.15 ± 0.83
P = 0.9

n = 65

n =6

4.39 ± 3.92

5.1 ± 2.9

MHV management in remnants with liver failure vs without liver failure

P = 0.27
1.87 ± 0.44
2.02 ± 0.57
P = 0.587

Our stepwise 3D-CT volumetry combined estimated
left remnant congestive- and non-congestive volumes
following virtual liver partition (Figure 2). Based on
[12,13]
the experience of the Kyoto and Nagoya groups
,
the extremely low (25%-33%) concordance between
donor RVBWR and RV/TLV, and the two reversible
remnant liver failures in our series, we differentiated
between right grafts inclusive of complete MHV and
left remnants with selective MHV-4A retention by
[16]
considering individual MHV anatomy patterns .
In 12 donors, the MHV was completely retained
with the left remnants, providing an intact twosectorial venous (MHV + LHV) drainage. In 10 cases, a
risky dominant (d)-MHV type was preserved because
of its particularly large congestive volume when
compared to the non-dominant (nd)-MHV (d-MHV
mean CV-index 41.2 ± 6.6 %RV vs nd-MHV mean CVindex 36.1 ± 12.2 %RV, p = 0.07, Mann-Whitney U
test). In 2 donors with nd-MHV, the decision to retain
the MHV with the left remnant was based on their
small donor RVBWR-RV/TLV constellation (0.6/28.2%
and 0.63/35%, Table 4).
The left sided MHV-4A drainage territory was
preserved in 4 of 59 donors who underwent
procurement of MHV-containing grafts as originally
[15]
described by our group . This decision was based on
an extremely small non-congestive-RVGWR (0.2-0.27)
(safely drained by LHV) in 2 cases (Table 4) and on
the anatomical characteristics of the MHV-4A/MHV-8
confluence into the MHV trunk in the other 2 instances.
Two (20%) of ten donors with estimated very
small RVBWR ≤ 0.65 (inclusive of two with RV/TLV <
30%) developed reversible liver failure. The MHV was
retained in two remnants (one with liver failure). Eight
remnants (one with liver failure) had no MHV. In three
non-liver failure remnants with extremely low noncongestive-RVBWR < 0.3 (safely drained by LHV), the
MHV was completely retained or the MHV-4A drainage
was preserved in the remnant liver (Table 4).

RV/TLV: Remnant volume percentage of total liver volume; MHV: Middle
hepatic vein; INR: International normalized ratio; Bili: Total bilirubin
(reference value 0.2-1.2).

than MHV-containing remnants (potentially suggesting
a “negative effect” of venous congestion in the early
postoperative liver function) (Table 3).

Postoperative donor morbidity

There were no donor deaths. Overall postoperative
donor morbidity was 15.5% (n = 11), including 6
[23]
(8.4%) grade Ⅲ-Ⅳ Dindo-Clavien complications .
There was no significant difference among remnants
with (n = 3, 25%) or without (n = 8, 13.6%) MHV
under their diverse volume conditions (p = 0.4077,
chi-square). Five medical complications included: 2
pleural effusions (1 in an MHV- and 1 in a non-MHV
remnant) requiring drainage (D-Ⅱ ), 1 pneumonia
in a non-MHV remnant (D-Ⅱ), and 2 reversible liver
failures (D-ⅣA). Six surgical morbidities included 2
bile leaks (1 in a non-MHV- and 1 in an MHV remnant)
associated with bilomas and treated with percutaneous
drainage (D-ⅢA), 1 ⅣC thrombosis treated surgically
in a non-MHV remnant (D-ⅢB), 1 subphrenic abscess
drained operatively in a non MHV remnant (D-ⅢB),
and 2 superficial wound infections (D-ⅠA).

Association of MHV management and remnant liver
failure in donors

Two (2.8%) donors developed reversible liver failure
(see SFSS definition). Neither of them had a history of
liver disease, experienced any adverse intraoperative
events, or developed surgical/medical complications.
Postoperative color doppler ultrasonography confirmed
intact porto-arterial inflow and hepatic venous outflow.
Case-1: 40 year old female, BMI 26, liver biopsy
< 10% steatosis, normal preoperative LFTs. MHVcontaining remnant with safely (MHV + LHV)drained-RVBWR of 0.63 (RV = 434 ml, RV/TLV
= 35%). Postoperatively developed grade 2°
encephalopathy, with peak Bilirubin of 26.5mg/dl and
INR of 3.7. Recovered completely after two courses of
plasmapheresis.
Case 2: 44-year-old male, BMI 27, liver biopsy <
10% steatosis, normal preoperative LFTs. Non-MHVcontaining remnant with RVBWR of 0.65 (RV = 584

WJG|www.wjgnet.com

DISCUSSION
Although a RV/TLV of at least 30%-35% is usually
[1,4,8]
required to avoid small-for-size syndrome (SFSS)
,
successful outcomes with RV/TLV < 30% have been
[6,7,11,24]
reported in the setting of optimal liver quality
.
Inclusion of the MHV with right grafts, which has
[1,4,7,25]
been reported to optimize graft function
but to
[1,26-28]
potentially impair remnant recovery
, has both
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3D CT volumetry and virtual liver partition

STEP Ⅰ

Remnant volume

TLV

RVBWR

RV/TLV

STEP Ⅱ

MHV anatomy
Dominant (d)
in TLV

Non-dominant (nd)
in TLV

CV-index vs non-congestive RVBWR

Figure 2 Stepwise 3D-computed tomography volumetry and virtual liver partition assessing congestive- and non-congestive (remnant) volumes. CVindex: Congestive volume percentage of remnant liver volume; 3-D: Three-dimensional; d: Dominant; MHV: Middle hepatic vein; nd: Non-dominant; RV/TLV: Remnant
volume percentage of total liver volume; RVBWR: Remnant-volume-(donor) body-weight ratio; non-congestive-RVBWR: Safely LHV drained remnant-volume-bodyweight ratio; TLV: Total liver volume.

Table 4 Middle hepatic vein management in small-for-size -remnants with remnant-volume (donor) body-weight-ratio ≤ 0.65
Donor

Remnant

Remnant

Remnant

Remnant

Remnant

n = 71

Total MHV
preserved
Yes
No
No
No
No
No
No
No
No
Yes

MHV-4A
preserved
Yes
No
No
No
Yes
No
Yes
No
No
Yes

volume

RV/TLV

RVBWR

434 mL
584 mL
512 mL
500 mL
429 mL
506 mL
536 mL
505 mL
389 mL
464 mL

35%
31%
32.9%
31.7%
35.1%
38%
35.6%
32%
28%
28.2%

1
2
3
4
5
6
7
8
9
10

0.63
0.65
0.62
0.64
0.60
0.65
0.62
0.63
0.60
0.60

Remnant CV-index

Remnant nc-RVBWR

SFSS

(LHV)
37.9%
40.2%
40.0%
37.2%
67.9%
14.8%
43.4%
39.4%
24.4%
55.4%

0.38
0.39
0.40
0.38
0.20
0.57
0.27
0.49
0.41
0.20

Yes
Yes
No
No
No
No
No
No
No
No

SFS: Small-for-size; SFSS: Small-for-size syndrome; LDLT: Live donor liver transplantation; MHV: Middle hepatic vein; MHV-4A: Branch of MHV draining
left medial sector; LHV: Left hepatic vein; RVBWR: Remnant-volume (donor) body-weight-ratio; Non-congestive-(nc)-RVBWR: Volume safely drained by
LHV; RV/TLV: Remnant volume percentage of total (donor) liver volume; CV-index: Potential congestion volume percentage of remnant liver volume.

[2,7,8,27,29-34]

supporters and detractors
. Currently, many
centres encourage a selective MHV management policy
[4,7,12]
based on individual graft/remnant characteristics
.
Our series allowed us to conclude that procurement
of right grafts including complete MHV itself did not
cause a significant volume loss in remnants. Indeed,
there were no significant RV, RV/TLV and RVBWR
differences between remnants with and without
MHV. We attributed this result to our “carving” liver
partitioning technique, in which the transection plane
exposed the MHV trunk on the resection surface of
either graft (MHV-harvest) or remnant (MHV-retention)
livers. There was no difference in donor morbidity
attributable to SFS-remnant-status or MHV inclusion
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(even with RVBWR and RV/TLV below the respective
marginal limits of < 0.6 and < 30%).
Our overall donor morbidity of 15.5% including
8.4% of Dindo-Clavien Ⅲ - Ⅳ type complications
were comparable with the data reported in the
[5,7,12]
literature
.
In the Kyoto series overall 10% of donors suffered
morbidity with similar incidence of complications who
required treatment between (-) MHV (13%) vs (+)
[12]
MHV (9%) remnants . Comparable, in our donors
the incidence of postoperative interventions did not
considerably differ between the non-MHV (5.1%)
and the MHV-contained (8.3%) remnants. In line
with the cited reports, all our donors returned to
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their pre-donation lifestyles. The subgroup analysis
[7]
of the Istambul series revealed a much higher
overall complication rate in non-MHV (22.4%) vs
MHV-contained remnants (7.8%) mirroring our own
experience with the tendency for (-) MHV remnants
to have more complications than (+) MHV ones (25%
vs14%).
Furthermore, our experience as well as that of
others did not reveal any late complications attributable
[7,35]
to remnant size or MHV-status
. Our virtual data
however, showed that the “sacrifice” of the left sided
MHV-4A/B drainage in remnants due to MHV inclusion
with the graft was associated with large congestive
volumes (CV-index of 36.9 ± 11.6 %RV) that resulted
in a significant reduction of non-congestive volumes
(non-congestive-RVBWR) safely drained by LHV. We
also observed a potentially (not statistically significant)
detrimental effect of venous congestion in non-MHV
remnants as illustrated by their elevated liver function
markers (INR, total bilirubin) in the early postoperative
period. These observations strongly correlate with
previous published reports.
[5]
In the study of the Clischy group segment Ⅳ
congestion was never seen on the postoperative
CT in donors who underwent a standard MHVexclusive right graft harvest, while in the setting of the
extended right graft inclusive of MHV procurements
84% remnants revealed venous congestion with the
[11]
morbidity rate of 37%. Yaprak et al
had observed
that RV/TLV ≤ 30% impacted donor outcome
(especially postoperative hyperbilirubinemia and major
complications) irrespective of donor RVBWR (< 0.6 or
> 0.6). In their experience, RVBWR < 0.6 significantly
affected liver function but not donor morbidity. In a
[7]
prospective study by Dayangac et al , procurement of
right grafts inclusive of MHV was not associated with
any additional donor risk except in SFS-remnants with
RV/TLV < 30% (57% complication rate and prolonged
postoperative hyperbilirubinemia). Others showed an
association between small remnant volume and donor
[1,11,36,37]
morbidity
. In our series the slightly higher
bilirubin and INR levels in SFS-remnants probably
resulted from a small RV.
The impact of remnant volume and remnant MHVstatus on remnant regeneration has been extensively
[1]
investigated. Belghiti et al observed that a small RV
accelerated early tissue regeneration, decreasing the
proportion of functional liver tissue and increasing
[7]
the risk of liver failure. Dayangac et al showed
that small non-MHV remnants had a significantly
higher volume increase after the first postoperative
week when compared to MHV remnants (76% and
50%, respectively). Similarly to our data, studies
from several other groups showed that the volume
regeneration rate of the total remnant liver (TLV) did
not significantly differ among extended and regular
[7,38,39]
right graft hepatectomies
. However, the observed
compensatory lateral hyper-growth effect attributable
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to transient venous congestion in the MHV drainage
area seems to reflect a competition between sectors,
with the lateral one dominating regardless of remnant
[40]
MHV status . The development of a procoagulant
state induced by the intense remnant regeneration as
described by the Paris group might help explain the Ⅳ
[1]
C thrombosis in one of our donors .
Our study revealed a very poor concordance
between donor RVBWR and RV/TLV cut offs in SFS
remnants (25%-33% in our series). Preoperative
volume assessment based solely on RV/TLV can be
misleading, particularly when compared to RVBWR of
[41]
remnant volume and donor BMI . RVBWR was also
found to be more specific than RV/TLV as a predictor
of postoperative outcomes in hepatic resections with
[6]
[42]
SFS remnants . Yigitler et al
observed a poor
correlation between RV/TLV ≤ 30% and RVBWR < 0.6
for SFS remnants after major hepatic resections. In
[11]
a retrospective analysis by Yaprak et al , remnants
with marginal RVBWR < 0.6 and RV/TLV ≤ 30%
constellation had the highest (52.2%) donor morbidity.
However, their observation was not reproduced in our
marginally small remnants.
Reversible liver failure occurred in MHV-inclusive as
well as in non-MHV remnants with remnant volumes
much above the commonly accepted limits (RVBWR
0.63-0.65 and RV/TLV 31%-35%). A retrospective
analysis of virtual and clinical data confirming a nonsteatosis in all donors on preoperative liver biopsy
suggested that extensive venous congestion (CVindex of 40.2% RV) likely accounted for liver failure in
case-2 [a non-MHV remnant with a tightly calculated
functional reserve (non-congestive-RVBWR) of 0.39].
On the contrary, in case-1 (liver failure in an MHVinclusive-remnant with intact bi-sectorial venous
drainage via MHV + LHV, no plausible explanation
could be found. A small-for-size syndrome (SFSS)
is a multifactorial process primarily associated with
insufficient functional liver mass that constitutes a life[22]
threatening condition for both donors and recipients .
Although, a “safe” donor RVBWR-RV/TLV constellation
seems to be the most effective parameter in donor
selection and remnant MHV management, “liver
quality” and “remnant volumes” are by no means
[11,43]
dogmatic parameters
. The “venous congestion”
and vice versa “non-congestive volume” association is
[44]
potentially a strong additional factor .
The main goal of our study was to evaluate
MHV management safety parameters to prevent
life-threatening liver failure in MHV inclusive-right
graft donors. As venous congestion in the drainage
territories of MHV-4A/B branches can occur after
procurement of right grafts containing MHV, congestive
and non-congestive volume characteristics for each
remnant should be carefully considered when making
a decision on safe MHV management in donors.
Our study also showed that 10 of 12 retained MHV
remnants had risky dominant d-MHV anatomy, with
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considerably large CV-index when compared to ndMHV, that required complete preservation of the MHV
in the left remnants. Based on our learning curve
[14]
experience (including two lethal SFSS grafts
and
two reversible SFSS remnants) and the experiences of
[12,13]
other groups
, we followed an “exclusion” scheme
aimed at identifying high risk donors unsuitable for
MHV-inclusive grafts. The main finding distinguishing
our series from previous ones is that MHV inclusion
with right grafts is not (by itself) associated with
prohibitively small remnant volumes. We individualized
MHV management by determining MHV-4A/B drained
congestive and safely LHV drained non-congestive
volume components.
All donors with (extremely small) non-congestiveRVBWR < 0.3 underwent successfully either complete
MHV- or MHV-4A remnant-preserving right graft
procurements. The two donors with reversible liver
failure in our series portray an enormous risk potential.
Further validation of our findings with a systematic
prospective clinical study will be required.
Our final conclusions include: (1) prevention of
liver failure in MHV inclusive right graft donors involves
consideration of both congestive and non-congestive
remnant volumes; (2) MHV management should be
individually based on MHV anatomy characteristics;
(3) non-congestive volumes represent an important
safety parameter in MHV management, especially in
the setting of SFS remnants; and (4) the RVBWRRV/TLV constellation seems to have a synergistic
(complementary) capacity for the identification of
marginally small remnants with the highest risk
potential of postoperative liver failure.

this is a good paper, which investigates the outcome of RL-LDLT donors with
remnant liver with or without the MHV trunk. It also analyzes the consistency
between RVBWR and remnant volumes/total liver volume.

REFERENCES
1

2
3

4
5

6

7

8

9

COMMENTS
COMMENTS
Background

10

The accurate magnitude of graft and remnant volumes comprises the most
critical parameter to preclude postoperative donor and recipient liver failure
in adult live donor liver transplantation (ALDLT). Middle hepatic vein (MHV)containing grafts are correlated with small remnants whose function may be
further compromised by immediate postoperative venous congestion of their
medial sector (segment 4A/B). The incident of small-for-size syndrome (SFSS)
in donors as a result of ineffective functional remnant volume is a steady notice
of the dispute encompassing venous congestion and MHV management.

11

12

Research frontiers

Current virtual data, disclosed that the “sacrifice” of the left sided MHV-4A/B
drainage in remnants due to MHV inclusion with the graft was related with large
congestive volumes (CV-index of 36.9 ± 11.6 %RV) that gave rise to a significant
reduction of non-congestive volumes (non-congestive-RVBWR) securely drained
by LHV. The authors likewise noted a potentially harmful outcome of venous
congestion in non-MHV remnants as demonstrated by their elevated liver
function tests (INR, total bilirubin) in the early postoperative period.

13

Innovations and breakthroughs

As yet, there are no published studies connecting the magnitude of functional
impairment and parenchymal congestion in non-MHV containing remnants, and
remnant volume limits for secure MHV enclosure with the right graft are still
indeterminate.

14

Applications

MHV management in adult live donor liver transplantation should be individually
based on MHV anatomy characteristics.

WJG|www.wjgnet.com

15

6015

Belghiti J, Liddo G, Raut V, Zappa M, Dokmak S, Vilgrain
V, Durand F, Dondéro F. “Inherent limitations” in donors:
control matched study of consequences following a right
hepatectomy for living donation and benign liver lesions. Ann
Surg 2012; 255: 528-533 [PMID: 22311131 DOI: 10.1097/
SLA.0b013e3182472152]
Marcos A. Right lobe living donor liver transplantation: a review.
Liver Transpl 2000; 6: 3-20 [PMID: 10648573 DOI: 10.1002/
lt.500060117]
Mittler J, Pascher A, Jonas S, Pratschke J, Neumann UP, Langrehr
JM, Neuhaus P. Adult living donor liver transplantation: living
donation of the right liver lobe. Langenbecks Arch Surg 2007; 392:
657-662 [PMID: 17443341 DOI: 10.1007/s00423-007-0187-0]
Fan ST. Live donor liver transplantation in adults. Transplantation 2006;
82: 723-732 [PMID: 17006315 DOI: 10.1097/01.tp.0000235171.17287.
f2]
Scatton O, Plasse M, Dondero F, Vilgrain V, Sauvanet A, Belghiti J.
Impact of localized congestion related to venous deprivation after
hepatectomy. Surgery 2008; 143: 483-489 [PMID: 18374045 DOI:
10.1016/j.surg.2007.11.002]
Chun YS, Ribero D, Abdalla EK, Madoff DC, Mortenson MM,
Wei SH, Vauthey JN. Comparison of two methods of future liver
remnant volume measurement. J Gastrointest Surg 2008; 12:
123-128 [PMID: 17924174 DOI: 10.1007/s11605-007-0323-8]
Dayangac M, Taner CB, Balci D, Memi I, Yaprak O, Akin B,
Duran C, Killi R, Ayanoglu O, Yuzer Y, Tokat Y. Use of middle
hepatic vein in right lobe living donor liver transplantation.
Transpl Int 2010; 23: 285-291 [PMID: 19821954 DOI: 10.1111/
j.1432-2277.2009.00978.x]
Fan ST, Lo CM, Liu CL, Yong BH, Chan JK, Ng IO. Safety of
donors in live donor liver transplantation using right lobe grafts.
Arch Surg 2000; 135: 336-340 [PMID: 10722038 DOI: 10.1001/
archsurg.135.3.336]
Heinemann A, Wischhusen F, Püschel K, Rogiers X. Standard
liver volume in the Caucasian population. Liver Transpl Surg 1999;
5: 366-368 [PMID: 10477836 DOI: 10.1002/lt.500050516]
Urata K, Kawasaki S, Matsunami H, Hashikura Y, Ikegami T,
Ishizone S, Momose Y, Komiyama A, Makuuchi M. Calculation
of child and adult standard liver volume for liver transplantation.
Hepatology 1995; 21: 1317-1321 [PMID: 7737637]
Yaprak O, Guler N, Altaca G, Dayangac M, Demirbas T, Akyildiz
M, Ulusoy L, Tokat Y, Yuzer Y. Ratio of remnant to total liver
volume or remnant to body weight: which one is more predictive
on donor outcomes? HPB (Oxford) 2012; 14: 476-482 [PMID:
22672550 DOI: 10.1111/j.1477-2574.2012.00483.x]
Asakuma M, Fujimoto Y, Bourquain H, Uryuhara K, Hayashi
M, Tanigawa N, Peitgen HO, Tanaka K. Graft selection algorithm
based on congestion volume for adult living donor liver
transplantation. Am J Transplant 2007; 7: 1788-1796 [PMID:
17524079 DOI: 10.1111/j.1600-6143.2007.01849.x]
Kamei H, Fujimoto Y, Nagai S, Suda R, Yamamoto H, Kiuchi
T. Impact of non-congestive graft size in living donor liver
transplantation: new indicator for additional vein reconstruction
in right liver graft. Liver Transpl 2007; 13: 1295-1301 [PMID:
17763381 DOI: 10.1002/lt.21231]
Radtke A, Sgourakis G, Molmenti EP, Beckebaum S, Cicinnati
V, Broelsch CE, Peitgen HO, Malagó M, Schroeder T. Computerassisted surgical planning in adult-to-adult live donor liver
transplantation: how much does it help? A single center experience.
Transplantation 2012; 94: 1138-1144 [PMID: 23222737 DOI:
10.1097/TP.0b013e31826e5970]
Radtke A, Sgourakis G, Molmenti EP, Schroeder T, Cicinnati VR,

May 21, 2015|Volume 21|Issue 19|

Radtke A et al . Liver failure in live donors of right grafts

16

17

18

19

20

21

22

23

24

25

26

27

28

29

Beckebaum S, Peitgen HO, Broelsch CE, Malagó M. The “carving”
liver partitioning technique for graft hepatectomy in live donor
liver transplantation: a single-center experience. Surgery 2013;
153: 189-199 [PMID: 22884089 DOI: 10.1016/j.surg.2012.06.027]
Radtke A, Sotiropoulos GC, Sgourakis G, Molmenti EP,
Schroeder T, Saner FH, Beckebaum S, Broelsch CE, Broering
DC, Malago M. Hepatic venous drainage: how much can we learn
from imaging studies? Anatomic-functional classification derived
from three-dimensional computed tomography reconstructions.
Transplantation 2010; 89: 1518-1525 [PMID: 20410853 DOI:
10.1097/TP.0b013e3181dd6bac]
Valentín-Gamazo C, Malagó M, Karliova M, Lutz JT, Frilling A,
Nadalin S, Testa G, Ruehm SG, Erim Y, Paul A, Lang H, Gerken
G, Broelsch CE. Experience after the evaluation of 700 potential
donors for living donor liver transplantation in a single center.
Liver Transpl 2004; 10: 1087-1096 [PMID: 15349997 DOI:
10.1002/lt.20223]
Schroeder T, Nadalin S, Stattaus J, Debatin JF, Malagó M,
Ruehm SG. Potential living liver donors: evaluation with an allin-one protocol with multi-detector row CT. Radiology 2002; 224:
586-591 [PMID: 12147860]
Fasel JH, Selle D, Evertsz CJ, Terrier F, Peitgen HO, Gailloud
P. Segmental anatomy of the liver: poor correlation with CT.
Radiology 1998; 206: 151-156 [PMID: 9423665 DOI: 10.1148/
radiology.206.1.9423665]
Radtke A, Schroeder T, Sotiropoulos GC, Molmenti E, Schenk
A, Paul A, Nadalin S, Lang H, Saner F, Peitgen HO, Broelsch CE,
Malagò M. Anatomical and physiological classification of hepatic
vein dominance applied to liver transplantation. Eur J Med Res
2005; 10: 187-194 [PMID: 15946917]
Malago M, Molmenti EP, Paul A, Nadalin S, Lang H, Radtke
A, Liu C, Frilling A, Biglarnia R, Broelsch CE. Hepatic venous
outflow reconstruction in right live donor liver transplantation.
Liver Transpl 2005; 11: 364-365 [PMID: 15719402 DOI: 10.1002/
lt.20369]
Clavien PA, Oberkofler CE, Raptis DA, Lehmann K, Rickenbacher
A, El-Badry AM. What is critical for liver surgery and partial liver
transplantation: size or quality? Hepatology 2010; 52: 715-729
[PMID: 20683967 DOI: 10.1002/hep.23713]
Dindo D, Demartines N, Clavien PA. Classification of surgical
complications: a new proposal with evaluation in a cohort of 6336
patients and results of a survey. Ann Surg 2004; 240: 205-213
[PMID: 15273542]
Liu CL, Fan ST. Adult-to-adult live-donor liver transplantation: the
current status. J Hepatobiliary Pancreat Surg 2006; 13: 110-116
[PMID: 16547671 DOI: 10.1007/s00534-005-1016-x]
Malagó M, Testa G, Frilling A, Nadalin S, Valentin-Gamazo C,
Paul A, Lang H, Treichel U, Cicinnati V, Gerken G, Broelsch
CE. Right living donor liver transplantation: an option for adult
patients: single institution experience with 74 patients. Ann Surg
2003; 238: 853-862; discussion 862-863 [PMID: 14631222 DOI:
10.1097/01.sla.0000098619.71694.74]
de Villa VH, Chen CL, Chen YS, Wang CC, Lin CC, Cheng
YF, Huang TL, Jawan B, Eng HL. Right lobe living donor liver
transplantation-addressing the middle hepatic vein controversy.
Ann Surg 2003; 238: 275-282 [PMID: 12894022 DOI: 10.1097/01.
SLA.0000081093.73347.28]
Fan ST, Lo CM, Liu CL, Wang WX, Wong J. Safety and
necessity of including the middle hepatic vein in the right lobe
graft in adult-to-adult live donor liver transplantation. Ann
Surg 2003; 238: 137-148 [PMID: 12832976 DOI: 10.1097/01.
sla.0000077921.38307.16]
Sano K, Makuuchi M, Miki K, Maema A, Sugawara Y,
Imamura H, Matsunami H, Takayama T. Evaluation of hepatic
venous congestion: proposed indication criteria for hepatic vein
reconstruction. Ann Surg 2002; 236: 241-247 [PMID: 12170030
DOI: 10.1097/01.SLA.0000021845.89475.00]
Akamatsu N, Sugawara Y, Kaneko J, Sano K, Imamura H, Kokudo
N, Makuuchi M. Effects of middle hepatic vein reconstruction on

WJG|www.wjgnet.com

30

31

32

33

34

35

36

37

38

39

40

41

42

43

44

6016

right liver graft regeneration. Transplantation 2003; 76: 832-837
[PMID: 14501863 DOI: 10.1097/01.TP.0000085080.37235.81]
Cattral MS, Molinari M, Vollmer CM, McGilvray I, Wei A,
Walsh M, Adcock L, Marks N, Lilly L, Girgrah N, Levy G, Greig
PD, Grant DR. Living-donor right hepatectomy with or without
inclusion of middle hepatic vein: comparison of morbidity and
outcome in 56 patients. Am J Transplant 2004; 4: 751-757 [PMID:
15084170 DOI: 10.1111/j.1600-6143.2004.00405.x]
Chan SC, Lo CM, Liu CL, Wong Y, Fan ST, Wong J. Tailoring
donor hepatectomy per segment 4 venous drainage in right lobe
live donor liver transplantation. Liver Transpl 2004; 10: 755-762
[PMID: 15162470 DOI: 10.1002/lt.20114]
Kasahara M, Takada Y, Fujimoto Y, Ogura Y, Ogawa K, Uryuhara
K, Yonekawa Y, Ueda M, Egawa H, Tanaka K. Impact of right lobe
with middle hepatic vein graft in living-donor liver transplantation.
Am J Transplant 2005; 5: 1339-1346 [PMID: 15888039 DOI:
10.1111/j.1600-6143.2005.00817.x]
Scatton O, Belghiti J, Dondero F, Goere D, Sommacale D, Plasse
M, Sauvanet A, Farges O, Vilgrain V, Durand F. Harvesting the
middle hepatic vein with a right hepatectomy does not increase the
risk for the donor. Liver Transpl 2004; 10: 71-76 [PMID: 14755781
DOI: 10.1002/lt.20015]
Yamamoto H, Maetani Y, Kiuchi T, Ito T, Kaihara S, Egawa H,
Itoh K, Kamiyama Y, Tanaka K. Background and clinical impact of
tissue congestion in right-lobe living-donor liver grafts: a magnetic
resonance imaging study. Transplantation 2003; 76: 164-169
[PMID: 12865804]
Sotiropoulos GC, Radtke A, Molmenti EP, Schroeder T, Baba HA,
Frilling A, Broelsch CE, Malagó M. Long-term follow-up after
right hepatectomy for adult living donation and attitudes toward
the procedure. Ann Surg 2011; 254: 694-700; discussion 700-701
[PMID: 22005145 DOI: 10.1097/SLA.0b013e31823594ae]
Breitenstein S, Apestegui C, Petrowsky H, Clavien PA. “State of
the art” in liver resection and living donor liver transplantation:
a worldwide survey of 100 liver centers. World J Surg 2009; 33:
797-803 [PMID: 19172348 DOI: 10.1007/s00268-008-9878-0]
Pomfret EA, Pomposelli JJ, Gordon FD, Erbay N, Lyn Price L,
Lewis WD, Jenkins RL. Liver regeneration and surgical outcome
in donors of right-lobe liver grafts. Transplantation 2003; 76: 5-10
[PMID: 12865779 DOI: 10.1097/01.TP.0000079064.08263.8E]
Hata S, Sugawara Y, Kishi Y, Niiya T, Kaneko J, Sano K, Imamura
H, Kokudo N, Makuuchi M. Volume regeneration after right liver
donation. Liver Transpl 2004; 10: 65-70 [PMID: 14755780 DOI:
10.1002/lt.20006]
Yokoi H, Isaji S, Yamagiwa K, Tabata M, Sakurai H, Usui M,
Mizuno S, Uemoto S. Donor outcome and liver regeneration after
right-lobe graft donation. Transpl Int 2005; 18: 915-922 [PMID:
16008740 DOI: 10.1111/j.1432-2277.2005.00158.x]
Schenk A, Hindennach M, Radtke A, Malagó M, Schroeder T,
Peitgen HO. Formation of venous collaterals and regeneration in
the donor remnant liver: volumetric analysis and three-dimensional
visualization. Transplant Proc 2009; 41: 2515-2517 [PMID:
19715965 DOI: 10.1016/j.transproceed.2009.06.110]
Vauthey JN, Abdalla EK, Doherty DA, Gertsch P, Fenstermacher
MJ, Loyer EM, Lerut J, Materne R, Wang X, Encarnacion A,
Herron D, Mathey C, Ferrari G, Charnsangavej C, Do KA, Denys
A. Body surface area and body weight predict total liver volume in
Western adults. Liver Transpl 2002; 8: 233-240 [PMID: 11910568
DOI: 10.1053/jlts.2002.31654]
Yigitler C, Farges O, Kianmanesh R, Regimbeau JM, Abdalla EK,
Belghiti J. The small remnant liver after major liver resection: how
common and how relevant? Liver Transpl 2003; 9: S18-S25 [PMID:
12942474 DOI: 10.1053/jlts.2003.50194]
Nagai S, Fujimoto Y, Kamei H, Nakamura T, Kiuchi T. Mild
hepatic macrovesicular steatosis may be a risk factor for
hyperbilirubinaemia in living liver donors following right
hepatectomy. Br J Surg 2009; 96: 437-444 [PMID: 19283738 DOI:
10.1002/bjs.6479]
Satou S, Sugawara Y, Tamura S, Kishi Y, Kaneko J, Matsui

May 21, 2015|Volume 21|Issue 19|

Radtke A et al . Liver failure in live donors of right grafts
2007; 39: 145-149 [PMID: 17275493 DOI: 10.1016/j.transprocee
d.2006.10.028]

Y, Kokudo N, Makuuchi M. Three-dimensional computed
tomography for planning donor hepatectomy. Transplant Proc

P- Reviewer: Vitale A, Wang WT, Zamani F
S- Editor: Ma YJ L- Editor: A E- Editor: Liu XM

WJG|www.wjgnet.com

6017

May 21, 2015|Volume 21|Issue 19|

Published by Baishideng Publishing Group Inc
8226 Regency Drive, Pleasanton, CA 94588, USA
Telephone: +1-925-223-8242
Fax: +1-925-223-8243
E-mail: bpgoffice@wjgnet.com
Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx
http://www.wjgnet.com

I S S N 1 0  0 7  -   9  3 2  7
19

9   7 7 10  0 7   9 3 2 0 45

© 2015 Baishideng Publishing Group Inc. All rights reserved.

